VINFAX 75

Description

VINFAX 75 contains Venlafaxine Hydrochloride 75 mg, a serotonin-norepinephrine reuptake inhibitor (SNRI) used in the management of depressive and anxiety disorders. It works by inhibiting the reuptake of serotonin (5-HT) and norepinephrine (NE) at the presynaptic neuronal membrane, thereby increasing their levels in the synaptic cleft. This dual mechanism enhances neurotransmission, leading to improved mood, reduced anxiety, and better emotional stability.

VINFAX 75 is indicated for the treatment of major depressive disorder, generalized anxiety disorder, social anxiety disorder, and panic disorder. It helps alleviate symptoms such as persistent sadness, loss of interest, excessive worry, and panic attacks, while also supporting long-term relapse prevention and overall improvement in quality of life.

Indications:

• Major Depressive Disorder (MDD)
• Generalized Anxiety Disorder (GAD)
• Social Anxiety Disorder (Social Phobia)
• Panic Disorder

Therapeutic Segment Positioning:

Antidepressant (Neurology)